Masimo Corporation

MASI

US5747951003

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2026-02-06 pm EST			5-day change	1st Jan Change
139.15 ^USD	+2.82%		+1.33%	+6.99%

Feb. 02	Masimo Insider Sold Shares Worth $2,555,570, According to a Recent SEC Filing	MT
Jan. 21	Clairity appoints founder Dr. Connie Lehman as chief executive officer; Joe Kiani named chairman of the board	RE

(MASI) Masimo Expects Q4 Revenue About $411M, vs. FactSet Est of $407.3M

Published on 01/12/2026 at 09:19 am EST

MT Newswires

Latest news about Masimo Corporation

Feb. 02	Masimo Insider Sold Shares Worth $2,555,570, According to a Recent SEC Filing	MT
Jan. 21	Clairity appoints founder Dr. Connie Lehman as chief executive officer; Joe Kiani named chairman of the board	RE
Jan. 14	Masimo Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 02:15 PM
Jan. 12	Masimo Reports Fiscal Q4, 2025 Preliminary Non-GAAP Earnings, Revenue	MT
Jan. 12	(MASI) Masimo Expects 2025 Revenue About $1.52B, vs. FactSet Est of $1.52B	MT
Jan. 12	(MASI) Masimo Expects 2025 Adjusted EPS Above $5.55, vs. FactSet Est of $5.48	MT
Jan. 12	(MASI) Masimo Expects Q4 Revenue About $411M, vs. FactSet Est of $407.3M	MT
Jan. 12	(MASI) Masimo Expects Q4 Adjusted EPS Above $1.54, vs. FactSet Est of $1.46	MT
Jan. 12	Masimo announces select preliminary 2025 financial results	RE
Dec. 03	Masimo Outlines Long-Term Targets, Reaffirms 2025 Guidance	MT
Dec. 03	Masimo Corporation - Analyst/Investor Day
Dec. 01	Masimo Corporation Enters Into $250 Million Unsecured Term Loan And $750 Million Unsecured Revolving Credit Facility With Option To Increase Aggregate Borrowing Capacity By $400 Million	CI
Nov. 18	Knobbe Martens guides Masimo to $634M win against Apple in patent infringement case	RE
Nov. 17	US Equity Indexes Drop as Volatility Jumps in Broad-Based Sell-Off	MT
Nov. 17	US Equity Indexes Slump in Final Leg of Trading	MT
Nov. 17	US Equity Indexes Head Lower Amid Declines in Technology	MT
Nov. 17	US Equity Indexes Mixed in Midday Trading	MT
Nov. 17	BofA Securities Initiates Masimo at Neutral With $162 Price Target	MT
Nov. 17	Sector Update: Tech Stocks Decline Premarket Monday	MT
Nov. 17	Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Monday as Markets Await Nvidia Earnings, Data Releases	MT
Nov. 17	Data Drought Breaks and Markets Brace for the Flood
Nov. 17	US ITC Opens Proceedings on Apple's Redesigned Watches as Part of Patent Dispute With Masimo	MT
Nov. 17	Apple Loses Trial Over Heart Monitoring Technology, Ordered to Pay $634 Million to Masimo	MT
Nov. 14	Masimo issues statement on California jury verdict finding patent infringement by Apple and awarding Masimo $634 million in damages	RE
Nov. 04	Masimo Corporation, Q3 2025 Earnings Call, Nov 04, 2025

Masimo Corporation is a global technology company that develops and produces a range of monitoring technologies, including measurements, sensors, patient monitors, and automation and connectivity solutions. The Company's segments include Healthcare and Non-healthcare. Its Healthcare segment develops, manufactures and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The Company's measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry and advanced rainbow Pulse CO-Oximetry parameters. The Company's Non-healthcare business develops, manufactures, markets, sells home sound integration technologies and accessories, along with licensing complete high performance in-vehicle audio systems under consumer brands, such as Bowers & Wilkins, Denon, Marantz, HEOS, Classe, Polk Audio, Boston Acoustics, and Definitive Technology.

Employees

3,600

Sector

Medical Equipment, Supplies & Distribution

Calendar

Feb. 26 - Q4 2025 Earnings Release

More about the company